Fabrication and evaluation of a γ-PGA-based self-assembly transferrin receptor-targeting anticancer drug carrier

References

• XuZChanHMLiCSynthesis, structure, and cytotoxicity of oxaliplatin-based platinum(IV) anticancer prodrugs bearing one axial fluorideInorg Chem201857148227823529943979
   PubMed Web of Science ®Google Scholar
• TikooKAliIYGuptaJGuptaC5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer ratsToxicol Lett20091912–315816619723570
   PubMed Web of Science ®Google Scholar
• GadAMEl-RaoufOMAEl-SayehBMFawzyHMAbdallahDMRenoprotective effects of montelukast in an experimental model of cisplatin nephrotoxicity in ratsJ Biochem Mol Toxicol20173112e21979
   Web of Science ®Google Scholar
• HsiehACLiuYEdlindMPThe translational landscape of mTOR signalling steers cancer initiation and metastasisNature20124857396556122367541
   PubMed Web of Science ®Google Scholar
• ChoHDuXRizziJPOn-target efficacy of a HIF-2α antagonist in preclinical kidney cancer modelsNature2016539762710711127595393
   PubMed Web of Science ®Google Scholar
• ChenWHillHChristieATargeting renal cell carcinoma with a HIF-2 antagonistNature2016539762711211727595394
   PubMed Web of Science ®Google Scholar
• AhmedMCheungNKEngineering anti-GD2 monoclonal antibodies for cancer immunotherapyFEBS Lett2014588228829724295643
   PubMed Web of Science ®Google Scholar
• MohitEHashemiAAllahyariMBreast cancer immunotherapy: monoclonal antibodies and peptide-based vaccinesExpert Rev Clin Immunol201410792796124867051
   PubMed Web of Science ®Google Scholar
• WangLShiCWrightFAMultifunctional telodendrimer nano-carriers restore synergy of bortezomib and doxorubicin in ovarian cancer treatmentCancer Res201777123293330528396359
   PubMed Web of Science ®Google Scholar
• ChangKHKimMSHongGWShinYNKimSHConversion of a murine monoclonal antibody A13 targeting epidermal growth factor receptor to a human monoclonal antibody by guided selectionExp Mol Med2012441525922064379
   PubMed Web of Science ®Google Scholar
• ShinTHSungESKimYJEnhancement of the tumor penetration of monoclonal antibody by fusion of a neuropilin-targeting peptide improves the antitumor efficacyMol Cancer Ther201413365166124435448
   PubMed Web of Science ®Google Scholar
• RudnickSILouJShallerCCInfluence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumorsCancer Res20117162250225921406401
   PubMed Web of Science ®Google Scholar
• PetrenkoVAJayannaPKPhage protein-targeted cancer nanomedicinesFEBS Lett2014588234134924269681
   PubMed Web of Science ®Google Scholar
• LiMFanXLiuJHuYHuangHSelection by phage display of nanobodies directed against hypoxia inducible factor-1α (HIF-1α)Biotechnol Appl Biochem201562673874525556956
   PubMed Web of Science ®Google Scholar
• Nogueira-LibrelottoDRCodevillaCFFarooqiARolimCMTransferrin-Conjugated Nanocarriers as Active-Targeted Drug Delivery Platforms for Cancer TherapyCurr Pharm Des201723345446627784246
   PubMed Web of Science ®Google Scholar
• TortorellaSKaragiannisTCThe significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systemsCurr Drug Deliv201411442744324387131
   PubMed Web of Science ®Google Scholar
• QianZMLiHSunHHoKTargeted drug delivery via the transferrin receptor-mediated endocytosis pathwayPharmacol Rev200254456158712429868
   PubMed Web of Science ®Google Scholar
• LiHSunHQianZMThe role of the transferrin-transferrin-receptor system in drug delivery and targetingTrends Pharmacol Sci200223520620912007993
   PubMed Web of Science ®Google Scholar
• HanLLiJHuangSPeptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agentBiomaterials201132112989299821277017
   PubMed Web of Science ®Google Scholar
• OhSKimBJSinghNPLaiHSasakiTSynthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptideCancer Lett20092741333918838215
   PubMed Web of Science ®Google Scholar
• LiuSGuoYHuangRGene and doxorubicin co-delivery system for targeting therapy of gliomaBiomaterials201233194907491622484049
   PubMed Web of Science ®Google Scholar
• GaoLYLiuXYChenCJCore-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA deliveryBiomaterials20143562066207824315577
   PubMed Web of Science ®Google Scholar
• HanLHuangRLiuSHuangSJiangCPeptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumorsMol Pharm2010762156216520857964
   PubMed Web of Science ®Google Scholar
• XiongYJiangWShenYA poly(γ, L-glutamic acid)-citric acid based nanoconjugate for cisplatin deliveryBiomaterials201233297182719322795851
   PubMed Web of Science ®Google Scholar
• ZhangLChangJZhaoYFabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritisInt J Nanomedicine2018132051206429670349
   PubMed Web of Science ®Google Scholar
• KhalilIRBurnsATRadeckaIBacterial-Derived Polymer Poly-y-Glutamic Acid (y-PGA)-based micro/nanoparticles as a delivery system for antimicrobials and other biomedical applicationsInt J Mol Sci2017182E31328157175
   PubMed Web of Science ®Google Scholar
• OgunleyeABhatAIrorereVUHillDWilliamsCRadeckaIPoly-γ-glutamic acid: production, properties and applicationsMicrobiology2015161Pt 111725288645
   PubMedGoogle Scholar
• LuoZGuoYLiuJMicrobial synthesis of poly-γ-glutamic acid: current progress, challenges, and future perspectivesBiotechnol Biofuels2016913427366207
   PubMed Web of Science ®Google Scholar
• ZhangLWangTLiQFabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivoInt J Nanomedicine2016112663267327354796
   PubMed Web of Science ®Google Scholar
• GabrielCMKeenerMGallouFLipshutzBHAmide and peptide bond formation in water at room temperatureOrg Lett201517163968397126251952
   PubMed Web of Science ®Google Scholar
• GengXYeHFengZSynthesis and characterization of cisplatin-loaded, EGFR-targeted biopolymer and in vitro evaluation for targeted deliveryJ Biomed Mater Res A2012100102839284822678850
   PubMedGoogle Scholar
• ZhangLGengXZhouJFabrication of poly(γ-glutamic acid)-based biopolymer as the targeted drug delivery system with enhanced cytotoxicity to APN/CD13 overexpressed cellsJ Drug Target201523545346125648136
   PubMed Web of Science ®Google Scholar
• FengZLiWXueXA novel GAP460 biopolymer for use as a carrier in drug-delivery applicationsJ Biomater Sci Polym Ed201122152023204021029517
   PubMed Web of Science ®Google Scholar
• DesaleSSCohenSMZhaoYKabanovAVBronichTKBiodegradable hybrid polymer micelles for combination drug therapy in ovarian cancerJ Control Release2013171333934823665258
   PubMed Web of Science ®Google Scholar
• LevinaTNSarychevaTGKniazevaESExperience in the use of flow scintillator Cobas Micros-18 OT in hematological practiceKlin Lab Diagn199710101820 Russian
   Google Scholar
• MajiRDeyNSSatapathyBSMukherjeeBMondalSPreparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapyInt J Nanomedicine201493107311825028549
   PubMed Web of Science ®Google Scholar
• YanFZhangCZhengYThe effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicityNanomedicine20106117017819447200
   PubMed Web of Science ®Google Scholar
• MiaoZRenGLiuHQiSWuSChengZPET of EGFR expression with an 18F-labeled affibody moleculeJ Nucl Med20125371110111822689926
   PubMed Web of Science ®Google Scholar
• CitoresLFerrerasJMMuñozRBenítezJJiménezPGirbésTTargeting cancer cells with transferrin conjugates containing the nontoxic type 2 ribosome-inactivating proteins nigrin b or ebulin lCancer Lett20021841293512104045
   PubMed Web of Science ®Google Scholar
• GreishKEnhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicinesJ Drug Target2007157–845746417671892
   PubMed Web of Science ®Google Scholar
• MaedaHSawaTKonnoTMechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCSJ Control Release2001741–3476111489482
   PubMed Web of Science ®Google Scholar
• GreishKFangJInutsukaTNagamitsuAMaedaHMacromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targetingClin Pharmacokinet200342131089110514531722
   PubMed Web of Science ®Google Scholar
• KharePJainAGulbakeASoniVJainNKJainSKBioconjugates: harnessing potential for effective therapeuticsCrit Rev Ther Drug Carrier Syst200926211915519673689
   PubMed Web of Science ®Google Scholar
• RamasamyTRuttalaHBGuptaBSmart chemistry-based nano-sized drug delivery systems for systemic applications: A comprehensive reviewJ Control Release201725822625328472638
   PubMed Web of Science ®Google Scholar
• RamasamyTRuttalaHBChitrapriyaNEngineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumorsActa Biomater20174813114327794477
   PubMed Web of Science ®Google Scholar
• RamasamyTHaidarZSTranTHLayer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugsActa Biomater201410125116512725169256
   PubMed Web of Science ®Google Scholar
• FangYTanJLimSSohSRupturing cancer cells by the expansion of functionalized stimuli-responsive hydrogelsNPG Asia Mater2018102e465
   Google Scholar
• FengZLiWXueXA novel GAP460 biopolymer for use as a carrier in drug-delivery applicationsJ Biomater Sci Polym Ed201122152023204021029517
   PubMed Web of Science ®Google Scholar
• FengZLaiYYeHHuangJXiXGWuZPoly (γ, L-glutamic acid)-cisplatin bioconjugate exhibits potent antitumor activity with low toxicity: a comparative study with clinically used platinum derivativesCancer Sci2010101112476248220813014
   PubMed Web of Science ®Google Scholar
• MorrisTTRuanYLewisVANarendranAGailerJFortification of blood plasma from cancer patients with human serum albumin decreases the concentration of cisplatin-derived toxic hydrolysis products in vitroMetallomics20146112034204125255207
   PubMed Web of Science ®Google Scholar